or Try an Advanced Search...

    Nervous System Disorders Stocks List

    Symbol Grade Name % Change
    HUGE F FSD Pharma Inc. - Class B Subordinate Voting Shares -15.43
    ACOR F Acorda Therapeutics, Inc. 0.00
    TRVN F Trevena, Inc. -3.81
    SAVA F Cassava Sciences, Inc. -1.70
    PASG F Passage Bio, Inc. 11.43
    SAGE F Sage Therapeutics, Inc. 1.57
    PRTC F PureTech Health plc -3.00
    IRWD F Ironwood Pharmaceuticals, Inc. 0.00
    BEAM D Beam Therapeutics Inc. -1.62
    ACAD D ACADIA Pharmaceuticals Inc. -1.29
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Central Nervous System Disorders Autoimmune Disease Chronic Pain Heart Failure Medicine Pain Abnormal Psychology Acute And Chronic Pain Acute Pain Alzheimer's Disease Analgesics Antibodies Antiemetics Antioxidants Bioenergy Biology Biomarkers Biopharmaceutical Cannabinoid Cannabis

    Related ETFs - A few ETFs which own one or more of the above listed Nervous System Disorders stocks.

    Symbol Grade Name Weight
    XPH D SPDR S&P Pharmaceuticals ETF 2.08
    IBRN C iShares Neuroscience and Healthcare ETF 1.73
    PILL F Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 1.59
    BBC C Virtus LifeSci Biotech Clinical Trials ETF 0.87
    IHE B iShares U.S. Pharmaceutical ETF 0.35
    View all Nervous System Disorders ETFs...
    Compare ETFs
    Compare XPH to BBC Compare XPH to IHE Compare XPH to PILL

        Nervous System Disorders Stocks Recent News

        Date Stock Title
        Jul 1 SAVA Cassava forms committee after US probe, researcher fraud
        Jul 1 SAVA Cassava Sciences: Latest Blow To Simufilam Thesis As Key Former Advisor Indicted
        Jul 1 SAVA Stocks to Watch Monday: Chewy, Boeing, NIO, Cassava Sciences
        Jul 1 SAVA Why Cassava Sciences Stock Is Sinking Today
        Jul 1 SAVA Cassava Sciences seesaws as SEC provides update on simufilam probe
        Jul 1 SAVA Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer's Drug Investigation
        Jul 1 SAVA Spirit Aerosystems, Tesla and Chewy rise premarket; GameStop, Boeing fall
        Jun 28 SAVA Cassava Sciences Shares Plunge on Indictment Against Former Advisor
        Jun 28 HUGE FSD Pharma provides Corporate Update
        Jun 28 HUGE Update: FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO
        Jun 28 SAVA Cassava Sciences Adviser Indicted on Fraud Charges
        Jun 28 SAVA Cassava Sciences Issues Statement on Former Science Advisor
        Jun 28 SAVA Cassava Sciences plunges 40% after simufilam researcher indicted on fraud charges
        Jun 28 HUGE FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd.
        Jun 27 BEAM Beam Therapeutics (BEAM) Begins Dosing in Phase I/II AATD Study
        Jun 27 HUGE FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia
        Jun 26 BEAM Beam Therapeutics Announces First Patient Dosed in the Phase 1/2 Study of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD)
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Central Nervous System Disorders Autoimmune Disease Chronic Pain Heart Failure Medicine Pain Abnormal Psychology Acute And Chronic Pain Acute Pain Alzheimer's Disease Analgesics Antibodies Antiemetics Antioxidants Bioenergy Biology Biomarkers Biopharmaceutical Cannabinoid Cannabis
        Nervous System Disorders

        Nervous system disorders are conditions that affect the functioning of the brain, spinal cord, and nerves. These disorders can affect the way the body moves, senses, thinks, and behaves. Examples of nervous system disorders include Alzheimer's disease, epilepsy, Parkinson's disease, multiple sclerosis, stroke, and spinal cord injuries.

        Browse All Tags